AAAAAA

   
Results: 1-12 |
Results: 12
Molecular pathology of parathyroid tumors
Authors: Carling, T
Citation: T. Carling, Molecular pathology of parathyroid tumors, TRENDS ENDO, 12(2), 2001, pp. 53-58
The NciI polymorphism in the cyclin D1 gene and sporadic primary hyperparathyroidism
Authors: Correa, P Lundgren, E Rastad, J Akerstrom, G Westin, G Carling, T
Citation: P. Correa et al., The NciI polymorphism in the cyclin D1 gene and sporadic primary hyperparathyroidism, J INTERN M, 250(6), 2001, pp. 516-520
Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily
Authors: Steele-Perkins, G Fang, W Yang, XH Van Gele, M Carling, T Gu, J Buyse, IM Fletcher, JA Liu, JS Bronson, R Chadwick, RB de la Chapelle, A Zhang, XK Speleman, F Huang, S
Citation: G. Steele-perkins et al., Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily, GENE DEV, 15(17), 2001, pp. 2250-2262
Vitamin D levels and primary hyperparathyroidism
Authors: Carling, T
Citation: T. Carling, Vitamin D levels and primary hyperparathyroidism, J CLIN END, 86(5), 2001, pp. 2328-2328
Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily
Authors: Du, Y Carling, T Fang, W Piao, Z Shen, JC Huang, S
Citation: Y. Du et al., Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily, CANCER RES, 61(22), 2001, pp. 8094-8099
Pathophysiology of primary hyperparathyroidism
Authors: Hellman, P Carling, T Rask, L Akerstrom, G
Citation: P. Hellman et al., Pathophysiology of primary hyperparathyroidism, HIST HISTOP, 15(2), 2000, pp. 619-627
Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism
Authors: Carling, T Rastad, J Szabo, E Westin, G Akerstrom, H
Citation: T. Carling et al., Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism, J CLIN END, 85(5), 2000, pp. 2000-2003
Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor
Authors: Carling, T Szabo, E Bai, M Ridefelt, P Westin, G Gustavsson, P Trivedi, S Hellman, P Brown, EM Dahl, N Rastad, J
Citation: T. Carling et al., Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor, J CLIN END, 85(5), 2000, pp. 2042-2047
Genetic Alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors
Authors: Hessman, O Lindberg, D Einarsson, A Lillhager, P Carling, T Grimelius, L Eriksson, B Akerstrom, G Westin, G Skogseid, B
Citation: O. Hessman et al., Genetic Alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors, GENE CHROM, 26(3), 1999, pp. 258-264
RAD51 as a candidate parathyroid tumour suppressor gene on chromosome 15q:absence of somatic mutations
Authors: Carling, T Imanishi, Y Gaz, RD Arnold, A
Citation: T. Carling et al., RAD51 as a candidate parathyroid tumour suppressor gene on chromosome 15q:absence of somatic mutations, CLIN ENDOCR, 51(4), 1999, pp. 403-407
The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels
Authors: Correa, P Rastad, J Schwarz, P Westin, G Kindmark, A Lundgren, E Akerstrom, G Carling, T
Citation: P. Correa et al., The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels, J CLIN END, 84(5), 1999, pp. 1690-1694
Analysis of the RAD54 gene on chromosome 1p as a potential tumor-suppressor gene in parathyroid adenomas
Authors: Carling, T Imanishi, Y Gaz, RD Arnold, A
Citation: T. Carling et al., Analysis of the RAD54 gene on chromosome 1p as a potential tumor-suppressor gene in parathyroid adenomas, INT J CANC, 83(1), 1999, pp. 80-82
Risultati: 1-12 |